Please login to the form below
complementary therapies
This page shows the latest complementary therapies news and features for those working in and with pharma, biotech and healthcare.
Takeda agrees $5.2bn deal to buy Ariad
Opportunities to acquire such high-quality, complementary targeted therapies do not come often, and we are very excited about the potential for this transaction to benefit patients, our shareholders, and other
Latest news
-
UCB launches arthritis exercise programme in the UK
However, the move comes just as Arthritis Research UK publish a report that criticises many complementary therapies for arthritis as lacking scientific evidence of efficacy. ... Rheumatoid arthritis was singled out in the report as being an area where
-
R&D news in brief
Last month, a report written by economist Christopher Smallwood and commissioned by the Prince of Wales said that complementary therapies, including herbal medicines, should be used more frequently by the NHS.
-
Doctors attack NHS support of complementary medicine
It criticised two initiatives - a government-funded guide on homeopathy for patients, and the Smallwood Report, which was commissioned by Prince Charles, and advocates greater access to complementary therapies. ... She said: ìPatients rightly expect to
-
New laws for alternative medicines in UK
The UK government will regulate aromatherapy, homoeopathy and other complementary therapies in a scheme due later in 2008. ... The NHS spends GBP 50m a year on complementary therapies, which will be covered by the new council.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Where next in Alzheimer’s disease R&D?
disease. Targeting tau. Tau is among the beneficiaries of the broader focus and emerging interest in combination therapies. ... These mechanisms may be complementary. “We think combination therapies between. antibodies and small molecules make a lot of
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine
- Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial
- Roche’s Tecentriq combo scores FDA approval for melanoma
- AstraZeneca escapes pandemic impact as new drugs bolster revenues
- Roche’s Actemra fails in late-stage severe COVID-19 study
- Live Webinar: Examining the Interface Between Healthcare & Society
- Novavax reports promising phase 1 results for coronavirus vaccine
- Merck enters agreement with Hanmi for investigational NASH drug
- AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
- Virtual Engagement At Porterhouse: Reflections on the past few months
- July 2020: diversity and inclusion in clinical trials round-up
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- ...
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
